Evidence map›Paper›PMID 40844800›Full record

Observational studyCritical care explorations2025

Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases.

Gretchen L Sacha, Abhijit Duggal, Anita J Reddy, Lu Wang, Seth R Bauer

Abstract readObservational Study
In one paragraph

Observational study in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gretchen L SachaDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.
Abhijit DuggalCritical Care Center, Cleveland Clinic, Cleveland, OH.
Anita J ReddyCritical Care Center, Cleveland Clinic, Cleveland, OH.
Lu WangDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.
Seth R BauerDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.

Funding

Personalized vasopressor therapy in patients with septic shockK08GM147806 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI SETH BAUER · 2022 to 2026
$886k
NIGMS NIH HHS K08 GM147806
6 · The paper itself

Abstract

importanceVasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown.

objectivesTo determine the association between norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality. DESIGN, SETTING, AND

participantsRetrospective, observational evaluation utilizing Medical Information Mart for Intensive Care-IV and electronic ICU Collaborative Research Database databases of adult patients with septic shock based on modified Sepsis-3 criteria receiving continuous infusion catecholamines. MAIN OUTCOMES AND MEASURES: The associations of norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality were evaluated with multivariable regression models.

resultsIn total, 1409 patients from 209 hospitals were included. At vasopressin initiation patients had a median (interquartile range) norepinephrine-equivalent dose 28.4 µg/min (16.4-42.6 µg/min), lactate concentration 3.7 mmol/L (2.5-6.2 mmol/L), and 5.6 hours (2.0-13.5 hr) had elapsed since shock onset. All three variables of interest were associated with in-hospital mortality. Three restricted cubic spline knots were identified where the relationship between norepinephrine-equivalent dose and in-hospital mortality changed substantially: 9, 28, and 72 µg/min. The odds of in-hospital mortality increased by 90% and 3.9-fold when comparing vasopressin initiation at norepinephrine-equivalent doses of 28 µg/min and 72 µg/min to 9 µg/min, respectively (adjusted odds ratio [OR], 1.90 [95% CI, 1.49-2.41] and 3.93 [95% CI, 2.74-5.64]). The odds of in-hospital mortality increased by 16% for every mmol/L in the lactate concentration at vasopressin initiation (adjusted OR, 1.16 [95% CI, 1.11-1.21]). Finally, the odds of in-hospital mortality increased by 3% for every hour in the time duration from shock onset to vasopressin initiation (adjusted OR, 1.03 [95% CI, 1.01-1.04]). CONCLUSIONS AND RELEVANCE: Earlier adjunctive vasopressin initiation may decrease mortality in patients with septic shock.

Indexed as

Hospital MortalityShock, SepticVasoconstrictor AgentsVasopressinsAgedDatabases, FactualFemaleHumansIntensive Care UnitsLactic AcidMaleMiddle AgedNorepinephrineRetrospective StudiesTime FactorsLactic AcidNorepinephrineVasoconstrictor AgentsVasopressinssepsisseptic shockshockvasoactive agentsvasopressinvasopressors

Identifiers

PMID40844800
PMCPMC12377302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.